Peficitinib, a novel compound targeting this specific kinase, represents a significant advance in the treatment of RA . Current clinical studies demonstrate that it can noticeably lessen swelling and https://peficitinib437765.blogdigy.com/peficitinib-a-promising-treatment-for-ra-joint-disease-69240813